SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maulcoin

Maulcoin is capturing attention as the community rallies behind its grassroots development and ambitious long-term goals, with supporters actively pushing for increased social media visibility and engagement. Investors are debating the project's staying power and potential for growth as they push toward new market capitalization milestones without traditional charting tools.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is seeing explosive, trend-driven momentum fueled by a combination of strong AI-related memory demand, a pending Nasdaq-100 index inclusion, and aggressive analyst price target hikes. While the community is sharply divided between those riding the parabolic surge and those warning of a potential blow-off top, active discussions remain heavily focused on the stock's massive year-over-year gains, high-stakes institutional flows, and the upcoming quarterly earnings report.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors remain polarized over its role in the era of agentic AI, with bulls highlighting the company's strong cash position and enterprise orchestration capabilities while bears express concerns about competition and growth deceleration. Community discussions are heavily focused on the stock's recent price volatility and whether current valuation levels present a value opportunity or a long-term trap.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is currently experiencing significant market volatility driven by a collision between political endorsements and aggressive short-selling campaigns. Investors are intensely debating the firm's defense-sector dominance and long-term valuation, with active discussions focused on whether recent price action represents a temporary selloff or a fundamental repricing of AI-integrated defense stocks.

FIGHT

FIGHT is experiencing a surge in trading volume driven by high-risk meme coin speculation and speculative links to political narratives. Market participants are actively debating the token's potential for exponential growth versus concerns regarding the sustainability of the underlying project.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is seeing massive momentum driven by a recent record price high and excitement surrounding its expansion into the World Liberty Financial ecosystem. The community is actively debating the token's long-term potential, with bulls pointing to its unique real-world utility in music and events while skeptics warn of potential volatility or a pump-and-dump scenario.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

The SPDR Dow Jones Industrial Average ETF (DIA) is currently at the center of market volatility as investors monitor escalating geopolitical tensions in the Middle East and the uncertainty surrounding U.S.-Iran negotiations. The community is actively debating the reliability of market-moving diplomatic headlines, expressing deep skepticism over potential ceasefire agreements and the sustainability of recent rallies amidst concerns regarding long-term inflation and the stability of the global energy supply.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is seeing a surge in investor interest driven by a perceived transformation into a strategic U.S. manufacturing hub for pharmaceutical ingredients and advanced materials, further buoyed by recent tariffs on imported foreign drug components. The community is actively debating the company's potential as a domestic supply chain solution and is closely watching for upcoming earnings and potential government-related contracts to validate this growth pivot.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending as a massive surge in investor confidence follows high-profile strategic partnerships with industry giants like Google and Tesla-linked Terafab. The community remains deeply divided between long-term bulls betting on a foundational turnaround in the AI infrastructure and foundry sector, and skeptics who are bracing for a pullback after a rapid, momentum-driven climb to multi-year highs.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

BNB is currently trending as Binance addresses investor legal claims and internal security fund reallocations while CZ comments on the evolving crypto cycle. The community remains focused on potential technical breakouts and broader volatility, with heightened discourse surrounding the impact of regulatory clarity on future adoption.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SG Americas Securities LLC Makes New Investment in Eledon Pharmaceuticals, Inc. $ELDN

SG Americas Securities LLC bought a new position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and...

Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines

Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines PR Newswire VANCOUVER, BC, April 6, 2026 Issued on behalf...

Short Interest in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Rises By 30.3%

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN - Get Free Report) saw a large increase in short interest in the month of March. As of March 13th, there was short interest totaling 8,417,915 shares, an...

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Receives Consensus Recommendation of "Hold" from Analysts

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN - Get Free Report) has received an average recommendation of "Hold" from the five brokerages that are presently covering the firm, Marketbeat.com reports...

Eledon Pharmaceuticals (NASDAQ:ELDN) Announces Quarterly Earnings Results, Beats Expectations By $0.10 EPS

Eledon Pharmaceuticals (NASDAQ:ELDN - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.10) EPS for the quarter, beating analysts' consensus estimates of ($0.20) by $0.10...

Eledon Pharmaceuticals Touts Tegoprubart Safety in BESTOW Kidney Transplant Data at Leerink Conference

Eledon Pharmaceuticals (NASDAQ:ELDN) used a presentation at the Leerink Partners Global Healthcare Conference to highlight what CEO David-Alexandre Gros described as a rapid expansion in clinical...

Eledon Pharmaceuticals (ELDN) to Release Quarterly Earnings on Thursday

Eledon Pharmaceuticals (NASDAQ:ELDN) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 19. (View Earnings Report at...

NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes

NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance...

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Given Average Recommendation of "Hold" by Brokerages

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN - Get Free Report) has been given an average rating of "Hold" by the five research firms that are currently covering the stock, MarketBeat Ratings reports...

Eledon Pharmaceuticals Highlights BESTOW Data, Phase III Plans and FDA Timeline for Tego at Conference

Eledon Pharmaceuticals (NASDAQ:ELDN) executives discussed recent clinical results and upcoming regulatory plans for its investigational immunosuppressive therapy, referred to in the discussion as...

Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company, which engages in development of therapies to protect transplanted organs and prevent rejection. The firm also focuses on development of therapy to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, a humanized IgG1 anti-CD40L antibody with high affinity for CD40 ligand (CD40L), a biological target with broad therapeutic potential. The company was founded on March 26, 2004 and is headquartered in Irvine, CA.

ELDN
Eledon Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ELDN News

ELDNEledon Pharmaceuticals Inc